Загрузка...
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis
Focal segmental glomerulosclerosis (FSGS) is a prevalent glomerular disease characterized by proteinuria, progression to end stage renal disease and recurrence of proteinuria after kidney transplantation in approximately one third of patients. It has been suggested that rituximab might treat recurre...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3719858/ https://ncbi.nlm.nih.gov/pubmed/21632984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3002231 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|